Entheon Biomedical ENTBF Stock
0.11 USD
{{ price }}
-4.045643%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
OTC Markets OTCPK
Market Cap
983.34K USD
LOW - HIGH [24H]
0.11
-
0.13 USD
VOLUME [24H]
344 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 USD
Entheon Biomedical Price Chart
Entheon Biomedical ENTBF Financial and Trading Overview
| Entheon Biomedical stock price | 0.11 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.01 - 0.08 USD |
| Volume | 3.35K USD |
| Avg. Volume | 11.5K USD |
| Market Cap | 1.11M USD |
| Beta (5Y Monthly) | 1.047719 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ENTBF Valuation Measures
| Enterprise Value | 588.43K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.5781412 |
| Price/Book (mrq) | 2.0555556 |
| Enterprise Value/Revenue | 1.9 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Entheon Biomedical Stock Price History
| Beta (5Y Monthly) | 1.047719 |
| 52-Week Change | -57.77% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
ENTBF Share Statistics
| Avg. Volume (3 month) | 11.5K USD |
| Avg. Daily Volume (10-Days) | 12.76K USD |
| Shares Outstanding | 59.09M |
| Float | 57.19M |
| Short Ratio | N/A |
| % Held by Insiders | 8.63% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | November 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -706.067% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.39% |
| Return on Equity (ttm) | -15.58% |
Income Statement
| Revenue (ttm) | 309.68K USD |
| Revenue Per Share (ttm) | 0.005 USD |
| Quarterly Revenue Growth (yoy) | 1248.19% |
| Gross Profit (ttm) | 189.68K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -613608 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 504.72K USD |
| Total Cash Per Share (mrq) | 0.009 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.287 |
| Book Value Per Share (mrq) | 0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -967271 USD |
| Levered Free Cash Flow (ttm) | -1357415 USD |
Profile of Entheon Biomedical
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 999 West Broadway |
| ZIP | V5Z 1K5 |
| Phone | 604-562-3932 |
| Website | https://www.entheonbiomedical.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Q&A For Entheon Biomedical Stock
What is a current ENTBF stock price?
Entheon Biomedical ENTBF stock price today per share is 0.11 USD.
How to purchase Entheon Biomedical stock?
You can buy ENTBF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Entheon Biomedical?
The stock symbol or ticker of Entheon Biomedical is ENTBF.
Which industry does the Entheon Biomedical company belong to?
The Entheon Biomedical industry is Biotechnology.
How many shares does Entheon Biomedical have in circulation?
The max supply of Entheon Biomedical shares is 8.86M.
What is Entheon Biomedical Price to Earnings Ratio (PE Ratio)?
Entheon Biomedical PE Ratio is now.
What was Entheon Biomedical earnings per share over the trailing 12 months (TTM)?
Entheon Biomedical EPS is -0.03 USD over the trailing 12 months.
Which sector does the Entheon Biomedical company belong to?
The Entheon Biomedical sector is Healthcare.